financetom
Business
financetom
/
Business
/
--Toll Brothers Keeps Quarterly Dividend at $0.23 a Share, Payable July 19 to Stockholders of Record as of July 5
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Toll Brothers Keeps Quarterly Dividend at $0.23 a Share, Payable July 19 to Stockholders of Record as of July 5
Jun 18, 2024 6:19 PM

04:58 PM EDT, 06/18/2024 (MT Newswires) --

Price: 117.92, Change: +0.42, Percent Change: +0.36

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
European agency offers support for struggling space sector
European agency offers support for struggling space sector
Nov 3, 2024
PARIS, Oct 24 (Reuters) - The European Space Agency unveiled measures on Thursday to speed up payments to the space industry in the face of mounting job cuts, while imposing greater scrutiny following a raft of cost overruns and delays. Director General Josef Aschbacher announced the plan after a council meeting of the 22-nation agency, a week after Airbus announced...
ZenaTech Buys Drone Design Patent From Former Parent Company -- Shares Jump Pre-Bell
ZenaTech Buys Drone Design Patent From Former Parent Company -- Shares Jump Pre-Bell
Nov 3, 2024
09:33 AM EDT, 10/24/2024 (MT Newswires) -- ZenaTech ( ZENA ) shares jumped in recent Thursday premarket trading after the software technology company said its ZenaDrone unit is acquiring a US patent for a design related to the second-generation design used in the ZenaDrone 1000 autonomous drone. ZenaTech ( ZENA ) said that the patent was purchased from ZenaTech's (...
GSK Reports 'Promising Data' From Phase 3 Study of RSV Vaccine Arexvy
GSK Reports 'Promising Data' From Phase 3 Study of RSV Vaccine Arexvy
Nov 3, 2024
09:57 AM EDT, 10/24/2024 (MT Newswires) -- GSK (GSK) reported Thursday that preliminary data from a phase 3 study of its respiratory syncytial virus vaccine Arexvy demonstrated its potential to help protect a larger group of adults at risk from getting RSV. The British pharmaceutical company said the trial, which involved patients between the ages of 18 and 49, could...
KKR Acquires 25% Stake In Enilive, Supporting Eni's Push For Energy Transition
KKR Acquires 25% Stake In Enilive, Supporting Eni's Push For Energy Transition
Nov 3, 2024
Eni S.p.A. and KKR & Co. Inc. ( KKR ) shares are trading higher on Thursday. KKR agreed to acquire a 25% stake in Enilive for €2.938 billion ($3.172 billion). The transaction includes a €500 million ($540 million) capital increase reserved for KKR and the purchase of €2.438 billion ($2.633 billion) in Enilive shares from Eni. The transaction price values Enilive's total...
Copyright 2023-2026 - www.financetom.com All Rights Reserved